Fresh Test For Cancer-Screening Firm Genetron After Nasdaq Exit (undefined:GTH)

microscope with lab glassware


Three years ago, cancer-testing company Genetron Health (NASDAQ:GTH) was a rising star in the field of innovative diagnostics, dazzling investors with a high-profile IPO on the U.S. stock market.

But like several other Chinese startups, the company found its

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *